220
Participants
Start Date
October 7, 2024
Primary Completion Date
February 1, 2027
Study Completion Date
March 27, 2030
Tarlatamab
Administered by SC injection.
RECRUITING
Freiburg Spital, Fribourg
RECRUITING
Chris OBrien Lifehouse, Camperdown
RECRUITING
Calvary Mater Newcastle Hospital, Waratah
RECRUITING
Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven
RECRUITING
The Alfred Hospital, Melbourne
RECRUITING
Centre Hospitalier Universitaire de Liege - Sart Tilman, Liège
RECRUITING
Kantonsspital Graubuenden, Chur
RECRUITING
Kantonsspital Winterthur, Winterthur
RECRUITING
Universitair Ziekenhuis Gent, Ghent
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Hospital Regional Universitario de Malaga, Málaga
RECRUITING
Koc Universitesi Hastanesi, Istanbul
RECRUITING
Hospital Universitari i Politecnic La Fe, Valencia
RECRUITING
Trinity Health Saint Joseph Mercy Ann Arbor, Ann Arbor
RECRUITING
Avera Cancer Institute, Sioux Falls
RECRUITING
University of Illinois Chicago, Chicago
RECRUITING
University of Texas MD Anderson Cancer Center, Houston
RECRUITING
University of Southern California, Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
Universitaetsklinikum Regensburg, Regensburg
RECRUITING
Universitaetsklinikum Wuerzburg, Würzburg
RECRUITING
Swedish Cancer Institute, Seattle
RECRUITING
Okayama University Hospital, Okayama
RECRUITING
Wakayama Medical University Hospital, Wakayama
RECRUITING
Uniwersyteckie Centrum Kliniczne, Gdansk
RECRUITING
Instytut Centrum Zdrowia Matki Polki, Lodz
RECRUITING
Wojewodzki Szpital im Sw Ojca Pio w Przemyslu, Przemyśl
RECRUITING
Hospital Universitari Vall d Hebron, Barcelona
RECRUITING
Adana Sehir Egitim ve Arastirma Hastanesi, Adana
RECRUITING
Ankara Bilkent Sehir Hastanesi, Ankara
Lead Sponsor
Amgen
INDUSTRY